finance.foundation / Companies / CSL (CSL)
Company · Healthcare · Plasma therapies & vaccines
CSL (CSL)
Australian biotech and one of the world's largest makers of plasma-derived therapies (CSL Behring), also active in influenza vaccines (Seqirus) and iron-deficiency and nephrology treatments (Vifor).
- Legal name
- CSL Limited
- Ticker
- CSL
- Exchange
- Australian Securities Exchange · MIC XASX
- Country
- Australia
- Sector
- Healthcare
- Industry
- Plasma therapies & vaccines
- Market cap ≈
- $65bn (approx., seed-0.4 · 2026-08-28)
- Reporting currency
- AUD
- Founded
- 1916
- Website
- www.csl.com
- LEI
- 529900ECSECK5ZDQTE14 (GLEIF)
- ISIN
- AU000000CSL8 (check digit validated)
- FIGI
- BBG001S7YNK1 (share class, OpenFIGI)
Graph connections view in graph →
lists_onAustralian Securities Exchange
domiciled_inAustralia
Sector peers — Healthcare
Approximate reference values from public sources · seed-0.4 · 2026-08-28 · not real-time. See data & methodology.
# this page as data
GET https://finance.foundation/api/v1/companies/csl